“The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s93, https://doi.org/10.25251/skin.4.supp.93.